$0.29
$-0.49 (-62.82%)
End-of-day quote: 02/17/2024
NasdaqCM:CNSP
CNS Pharmaceuticals Annual Report
| Year | Year | ||
|---|---|---|---|
| Rev. | Revenue |
|
|
| GM % | Gross Margin % |
|
|
| OM | Operating Margin |
|
|
| EPS | Earnings Per Share |
|
$0.00 |
| Div. | Dividends |
|
|
| PR % | Payout Ratio % |
|
|
| Sha. | Shares |
|
|
| OCF | Operating Cash Flow |
|
|
| FCF | Free Cash Flow |
|
|
| FCFS | Free Cash Flow Per Share |
|
